125742 S1 M5 c4591001 A report cci metastatic tumour

Document text

CCI_Metastatic tumou r
MedDRA Dictionary Version: 230
Status: ACTIVETerm Name: CCI_Metastatic tumourCode: 90002954Extension: CCIReport Date/Time: 27-Oct-2020:10:48:51 AM EDT
Term Code Level Category Weight Scope
Metastatic neoplasm 10061289 PT
Metastatic malignant melanoma 10027480 PT
Metastatic lymphoma 10071541 PT
Metastatic glucagonoma 10075245 PT
Metastatic glioma 10063157 PT
Metastatic gastric cancer 10063916 PT
Metastatic choriocarcinoma 10071532 PT
Metastatic carcinoma of the bladder 10057352 PTMetastatic carcinoid tumour 10068115 PTMetastatic bronchial carcinoma 10058306 PTMetastasis 10062194 PTMetastases to vagina 10075555 PTMetastases to uterus 10049726 PTMetastases to urinary tract 10056251 PTMetastases to trachea 10051685 PTMetastases to tonsils 10077476 PTMetastases to thyroid 10049723 PTMetastases to thorax 10051684 PTMetastases to the respiratory system 10061600 PTMetastases to the mediastinum 10027469 PTMetastases to testicle 10051683 PTMetastases to stomach 10049718 PTMetastases to spleen 10051682 PTMetastases to spine 10027468 PTMetastases to spinal cord 10078267 PTMetastases to soft tissue 10062197 PTMetastases to skin 10027465 PTMetastases to salivary gland 10051681 PTMetastases to retroperitoneum 10051680 PTMetastases to reproductive organ 10061288 PTMetastases to rectum 10051679 PTMetastases to prostate 10051678 PT
090177e196edc74a\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023951
Metastases to pleura 10027463 PT
Metastases to placenta 10049725 PT
Metastases to pituitary gland 10049728 PTMetastases to pharynx 10051677 PTMetastases to peritoneum 10051676 PTMetastases to peripheral vascular system 10058307 PTMetastases to peripheral nervous system 10051674 PTMetastases to perineum 10051673 PTMetastases to penis 10051672 PTMetastases to pelvis 10070913 PTMetastases to pancreas 10049721 PTMetastases to ovary 10027462 PTMetastases to oesophagus 10051671 PTMetastases to nervous system 10061287 PTMetastases to neck 10027460 PTMetastases to nasal sinuses 10051670 PTMetastases to muscle 10049730 PTMetastases to mouth 10051669 PTMetastases to meninges 10051696 PTMetastases to lymph nodes 10027459 PTMetastases to lung 10027458 PTMetastases to liver 10027457 PTMetastases to larynx 10051668 PTIntestinal metastasis 10080311 PTMetastases to kidney 10027455 PTMetastases to heart 10049717 PTMetastases to gastrointestinal tract 10062196 PTMetastases to gallbladder 10051667 PTMetastases to fallopian tube 10049727 PTMetastases to eye 10049724 PTMetastases to Eustachian tube 10051666 PTMetastases to diaphragm 10051665 PTMetastases to chest wall 10051663 PTMetastases to central nervous system 10059282 PTMetastases to breast 10027454 PTMetastases to bone marrow 10051662 PTMetastases to bone 10027452 PTMetastases to bladder 10049722 PTMetastases to biliary tract 10062195 PTMetastases to adrenals 10027451 PTMetastases to abdominal wall 10051664 PTMetastases to abdominal cavity 10027450 PTMalignant neoplasm of pleura metastatic 10072432 PTMalignant mesenchymoma metastatic 10025674 PTMalignant meningioma metastatic 10077758 PTMalignant haemangiopericytoma metastatic 10025567 PTMalignant fibrous histiocytoma metastatic 10025554 PTMalignant ascites 10025538 PT
090177e196edc74a\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023952
Lymphangiosis carcinomatosa 10053132 PT
Lung squamous cell carcinoma metastatic 10071533 PT
Lung cancer metastatic 10050017 PT
Liposarcoma metastatic 10024629 PT
Leiomyosarcoma metastatic 10024191 PT
Laryngeal cancer metastatic 10070902 PT
Large cell lung cancer metastatic 10069730 PT
Hepatic cancer metastatic 10055110 PT
Head and neck cancer metastatic 10071540 PT
Germ cell cancer metastatic 10068971 PT
Gastrointestinal cancer metastatic 10053548 PT
Gallbladder cancer metastatic 10066879 PT
Fibrosarcoma metastatic 10016635 PT
Fallopian tube cancer metastatic 10016182 PT
Extraskeletal osteosarcoma metastatic 10015849 PT
Extraskeletal chondrosarcoma metastatic 10015840 PT
Extra-osseous Ewing's sarcoma metastatic 10015761 PT
Ewing's sarcoma metastatic 10015562 PT
Epithelioid sarcoma metastatic 10015101 PT
Endometrial sarcoma metastatic 10067065 PT
Endometrial cancer metastatic 10014734 PT
Dermatofibrosarcoma protuberans metastatic 10073574 PT
Colorectal cancer metastatic 10052358 PT
Colon cancer metastatic 10055114 PT
Chondrosarcoma metastatic 10008736 PT
Cervix cancer metastatic 10055094 PT
Breast sarcoma metastatic 10068583 PT
Breast cancer metastatic 10055113 PT
Breast angiosarcoma metastatic 10072814 PT
Brain cancer metastatic 10055093 PT
Bone cancer metastatic 10055101 PT
Bladder transitional cell carcinoma metastatic 10071664 PT
Biliary cancer metastatic 10055111 PT
Angiosarcoma non-metastatic 10057700 PT
Angiosarcoma metastatic 10002477 PT
Anal cancer metastatic 10055096 PT
Alveolar soft part sarcoma metastatic 10001884 PT
Adrenal gland cancer metastatic 10055095 PT
Vulval cancer metastatic 10047742 PT
Vaginal cancer metastatic 10046887 PT
Urethral melanoma metastatic 10072793 PT
Urethral cancer metastatic 10046433 PT
Ureteric cancer metastatic 10046394 PT
Transitional cell carcinoma metastatic 10071080 PT
Transitional cell cancer of renal pelvis and ureter metastatic 10044406 PT
Tonsil cancer metastatic 10072792 PT
Tongue cancer metastatic 10055109 PT
Thyroid cancer metastatic 10055107 PT
090177e196edc74a\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023953
Thymic cancer metastatic 10055108 PT
Testicular germ cell cancer metastatic 10068694 PT
Testicular cancer metastatic 10055103 PT
Synovial sarcoma metastatic 10042864 PT
Small intestine carcinoma metastatic 10041121 PT
Small cell lung cancer metastatic 10059514 PT
Skin squamous cell carcinoma metastatic 10077314 PT
Skin cancer metastatic 10055115 PT
Sinus cancer metastatic 10055105 PT
Sarcoma metastatic 10068595 PT
Retroperitoneal neoplasm metastatic 10062485 PT
Renal cancer metastatic 10050018 PT
Rectosigmoid cancer metastatic 10069728 PT
Rectal cancer metastatic 10055097 PT
Prostate cancer metastatic 10036909 PT
Primitive neuroectodermal tumour metastatic 10068910 PT
Pituitary cancer metastatic 10055106 PT
Pharyngeal cancer metastatic 10055104 PT
Peritoneal carcinoma metastatic 10068974 PT
Peripheral neuroepithelioma of bone metastatic 10034603 PT
Penis carcinoma metastatic 10034329 PT
Pancreatic neuroendocrine tumour metastatic 10068909 PT
Pancreatic carcinoma metastatic 10033610 PT
Ovarian epithelial cancer metastatic 10033158 PT
Ovarian cancer metastatic 10057529 PT
Otic cancer metastatic 10055100 PT
Osteosarcoma metastatic 10031294 PT
Oral cavity cancer metastatic 10055098 PT
Oesophageal squamous cell carcinoma metastatic 10058527 PT
Oesophageal cancer metastatic 10055102 PT
Ocular cancer metastatic 10055099 PT
Non-small cell lung cancer metastatic 10059515 PT
Non-Hodgkin's lymphoma metastatic 10071535 PT
Neurofibrosarcoma metastatic 10029274 PT
Neuroendocrine tumour of the lung metastatic 10078175 PT
Neuroendocrine carcinoma metastatic 10071542 PT
Metastatic uterine cancer 10068116 PT
Metastatic squamous cell carcinoma 10063569 PT
Metastatic salivary gland cancer 10066882 PT
Metastatic renal cell carcinoma 10050513 PT
Metastatic pulmonary embolism 10069909 PT
Metastatic ocular melanoma 10068117 PT
Metastatic nervous system neoplasm 10077703 PT
090177e196edc74a\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023954